Set Up Your Collaborative Team for Success: A Guideline for Advanced Practice Provider/Physician Team-Based Care in Oncology
By Tammy Triglianos, DNP, ANP-BC, AOCNP, Ethan Basch, MD, MSc, FASCO, and Matthew Milowsky, MD, FASCONot only are the number of advanced practice providers (APPs) practicing in oncology continuing to increase, but the role of APPs caring for patients with cancer continues to expand. APPs have significant roles in providing continuity of patient care...
Peer Coaching May Improve Genetic Testing for Cancer Patients
Incorporating peer coaching from a genetics expert into the community oncology setting helped increase uptake of germline genetic testing among eligible patients. Medscape Medical News
'Very Good News' About Localized Prostate Cancer: ProtecT Results
Men with newly diagnosed non-metastatic prostate cancer who were randomly assigned to surgery, radiation, or active monitoring had similar overall and prostate cancer-specific survival rates after 15 years. Medscape Medical News
Can Particles in Dairy and Beef Cause Cancer and MS?
A Nobel Prize winner suspects that bovine meat and milk factors may cause cancer, but scientific authorities are skeptical. Medscape Medical News
Biden Budget Proposal Includes Billions for Cancer Moonshot
President Joe Biden's 2024 budget proposal includes a hefty investment in cancer prevention and treatment. Medscape Medical News
Defensiveness May Drive Refusal for Colon Cancer Screening
Some adults don’t consider screening to be a priority, while others were under the impression that a healthy diet with regular bowel movements negates the need for screening, a survey found. MDedge News
Chemo Doesn't Improve Lung Adenocarcinoma Survival in Most
Only never-smokers with high PDL-1 expression lived longer when chemotherapy was added to upfront PD-(L)1 blockers. The study was published as a preprint and has not yet been peer reviewed. First Look
Biologics May Delay Arthritis in Psoriasis Patients
Treatment with the interleukin-12/23 inhibitor ustekinumab or interleukin-23 inhibitors was linked to a lower risk of developing psoriatic arthritis compared with tumor necrosis factor inhibitors. MDedge News
Long-Term Survival Benefit With Olaparib in Mets Breast Cancer?
Follow-up findings from the phase 3 OlympiAD trial support the possibility of long-term survival benefit with olaparib when used in the first-line metastatic setting. Medscape Medical News
Popular Book by USC Oncologist Pulled Because of Plagiarism
The LA Times identified at least 95 instances of plagiarism, leading to suspension of sales ahead of the book's planned March 7 release. Medscape Medical News
